Table 3. Performance of Japanese risk scores for predicting IVIG resistance (by age group)
| Group | Risk score | Sens | Spec | PPV | NPV | Acc | AUC |
| Overall(n = 10,352) | Kobayashi | 0.46 | 0.77 | 0.28 | 0.88 | 0.72 | 0.66 |
| Egami | 0.47 | 0.73 | 0.26 | 0.88 | 0.69 | 0.64 |
| Sano | 0.33 | 0.86 | 0.33 | 0.87 | 0.78 | 0.64 |
| < 6 m(n = 957) | Kobayashi | 0.45 | 0.77 | 0.20 | 0.91 | 0.73 | 0.66 |
| Egami | 0.47 | 0.68 | 0.17 | 0.91 | 0.66 | 0.63 |
| Sano | 0.27 | 0.88 | 0.23 | 0.90 | 0.81 | 0.61 |
| 6–11 m(n = 1,354) | Kobayashi | 0.53 | 0.73 | 0.22 | 0.92 | 0.71 | 0.66 |
| Egami | 0.49 | 0.77 | 0.23 | 0.91 | 0.74 | 0.68 |
| Sano | 0.35 | 0.90 | 0.33 | 0.91 | 0.83 | 0.66 |
| 12–59 m(n = 6,799) | Kobayashi | 0.44 | 0.79 | 0.30 | 0.87 | 0.73 | 0.66 |
| Egami | 0.46 | 0.73 | 0.26 | 0.87 | 0.69 | 0.63 |
| Sano | 0.34 | 0.86 | 0.33 | 0.86 | 0.77 | 0.64 |
| ≥ 60 m(n = 1,242) | Kobayashi | 0.50 | 0.74 | 0.32 | 0.86 | 0.69 | 0.68 |
| Egami | 0.48 | 0.74 | 0.30 | 0.86 | 0.69 | 0.65 |
| Sano | 0.31 | 0.86 | 0.34 | 0.84 | 0.75 | 0.62 |
IVIG: intravenous immunoglobulin; Sens, sensitivity; Spec, specificity; PPV, positive predictive value; NPV, negative predictive value; Acc, accuracy; AUC, area under the receiver operating characteristic curve.